CHRONIC LYMPHOCYTIC LEUKAEMIA

Part 1 - Welcome and Introduction - Dr. Shweta Surve, AstraZeneca

Part 2 - Introduction of guest speaker - Dr. M B Agarwal, Mumbai

Part 3 - Expert Opinion on RealWorld Challenges with BTK inhibitors in CLL Management - DrJohn Pagel

Part 4 - Case 1:Treatment nave CLL - Dr. Kishore Kumar, Chennai

Part 5 - Case 2:Relapsed refractory CLL - Dr. Mukul Aggarwal, New Delhi

Part 6 - Case 3:High-risk CLL - Dr. Dharma Choudhary, New Delhi

Part 7 - panel discussion - Dr. Dharma Choudhary, New Delhi

Part 8 - Vote of thanks - Dr. Shweta Surve , AstraZeneca